Cargando…
Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease
Alcohol liver disease (ALD) is a major cause of liver-related mortality globally, yet there remains an unmet demand for approved ALD drugs. The pathogenesis of ALD involves perturbations to the intestinal barrier and subsequent translocation of bacterial endotoxin that, acting through toll-like rece...
Autores principales: | Tang, Xiao-Han, Melis, Marta, Mai, Karen, Gudas, Lorraine J., Trasino, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012525/ https://www.ncbi.nlm.nih.gov/pubmed/33815111 http://dx.doi.org/10.3389/fphar.2021.630557 |
Ejemplares similares
-
Retinoids in the Pathogenesis and Treatment of Liver Diseases
por: Melis, Marta, et al.
Publicado: (2022) -
Retinoic Acid Receptor β Loss in Hepatocytes Increases Steatosis and Elevates the Integrated Stress Response in Alcohol-Associated Liver Disease
por: Melis, Marta, et al.
Publicado: (2023) -
Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease
por: Melis, Marta, et al.
Publicado: (2019) -
Obesity Leads to Tissue, but not Serum Vitamin A Deficiency
por: Trasino, Steven E., et al.
Publicado: (2015) -
Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota
por: Sun, E., et al.
Publicado: (2023)